TRAVERSA SERGIO bought RLMD
November 5, 2025 · Form 4 insider transaction
TRAVERSA SERGIO bought 272,500 shares of Relmada Therapeutics, Inc. at $2.20 per share, a transaction worth $599.5K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
272,500
Price
$2.20
Total value
$599.5K
InsiderTRAVERSA SERGIO
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 5, 2025
Filing dateNovember 6, 2025
Shares owned after1,272,500
OwnershipDirect
10b5-1 planNo
AmendedNo